[PDF] Top 20 Formulation and Evaluation of Sustained Release Matrix Tablets of Zidovudine

... (immediate sustained or controlled release) and the design of dosage forms (either solid dispersion or liquid) must be developed within the intrinsic characteristics of GI physiology pharmacokinetics, ... See full document

... delivery. Sustained release dosage forms have been demonstrated to improve therapeutic efficiency by maintenance of a steady drug plasma ...concentration. Sustained release, prolonged ... See full document

... slow release, about 20- 35% in 24 hrs and hence these formulations are considered not suitable for sustained release of ...drug release from the matrix tablets. Drug ... See full document

... Sustained release products provide an immediate release of drug that promptly produces the desired therapeutic effect, followed by gradual release of additional amounts of drug to maintain ... See full document

... The method of development of Nifedipine matrix tablets is Direct Compression method.Direct compression is a popular choice. The prime advantage of direct compression over wet granulation is economic since ... See full document

... Captopril is an orally potent and specific angiotensin converting enzyme inhibitor, it inhibits the conversion of angiotensin-I to angiotensin-II. It is used therapeutically to treat hypertension and heart failure. ... See full document

... Extended release drug formulations have been used since ...extended release product will optimize therapeutic effect and safety of a drug at the same time improves patient convenience and compliance, by ... See full document

... evaluate sustained release matrix tablets of glibenclamide capable of delivering drug at nearly constant rate, suitable for once a day ...for formulation in a sustained ... See full document

... in tablets and capsules, and to a more limited extent in lyophilized products and infant ...of tablets by the wet-granulation method or when milling during processing is carried out, since the fine size ... See full document

... the release of drugs from a matrix at levels of 10% to 80% w/w in tablets and capsules (Raymond and Paul, ...drug release from HPMC K100M matrices showed in Table 23 and Figure ...burst ... See full document

... drug release profile of Ibuprofen from microbeads was examined in simulated gastric fluid ...The release of drug from the microbeads was pH dependent, showed negligible drug release in ...drug ... See full document

... The release rate of gliclazide from matrix tablets was determined using United States Pharmacopoeia dissolution testing apparatus I (Basket method; Veego Scientific VDA-8DR, Mumbai, ...each ... See full document

... controlled release dosage form. It has been studied that a matrix tablet containing hydroxypropyl methyl cellulose K100M, ethyl cellulose and xanthan gum for oral controlled delivery of Losartan Potassium ... See full document

... therapeutiсѕ. Matrix ѕyѕtem iѕ the releaѕe ѕyѕtem ѡhiсh prоlоngѕ and соntrоlѕ the releaѕe оf the drug, ѡhiсh iѕ diѕѕоlved оr ...A matrix iѕ defined aѕ a ѡell-mixed соmpоѕite оf оne оr mоre drugѕ ѡith ... See full document

... tapentadol-SR tablets formulated (F1-F16) didn’t show any visual defects like capping, chipping and lamination after ...Tapentadol-SR tablets (Table.4) showed that tablets indicated good mechanical ... See full document

... the release kineticsfor in vitro analysis of the release ...drug release rate is independent of the concentration [17, ...the release from the system where the release rate is ... See full document

... Drug Release [11&12] : To study the mechanism of drug release from the matrix tablets, the drug release data were fitted to various kinetic models like zero order, first order, ... See full document

... of Sustained release tablets of levofloxacin were prepared by direct compression technique with each batch containing 100 tablets with 250 mg of ...the tablets were evaluated for weight ... See full document

... Drug-excipient compatibility studies: Assessment of possible incompatibilities between an active drug substance and different excipients forms an important part of the pre-formulation stage during the development ... See full document

... SR tablets, developed by Kollidon SR, microcrystalline cellulose and magnesium ...were sustained for 24hrs but based on dissimilarity factor (f1) and similarity factor (f2) values F3, F4 and F5 were ... See full document